BMT Tandem Meeting
Presentation Preliminary Results from the AdVise Study Evaluating Brincidofovir (BCV, CMX001) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection

Feb 12, 2015

Speaker: Michael Grimley, MD